Popovici Vlad, Goldstein Darlene R, Antonov Janine, Jaggi Rolf, Delorenzi Mauro, Wirapati Pratyaksha
Bioinformatics Core Facility, Swiss Institute of Bioinformatics, CH-1015 Lausanne, Switzerland.
BMC Bioinformatics. 2009 Feb 2;10:42. doi: 10.1186/1471-2105-10-42.
Gene expression analysis has emerged as a major biological research area, with real-time quantitative reverse transcription PCR (RT-QPCR) being one of the most accurate and widely used techniques for expression profiling of selected genes. In order to obtain results that are comparable across assays, a stable normalization strategy is required. In general, the normalization of PCR measurements between different samples uses one to several control genes (e.g. housekeeping genes), from which a baseline reference level is constructed. Thus, the choice of the control genes is of utmost importance, yet there is not a generally accepted standard technique for screening a large number of candidates and identifying the best ones.
We propose a novel approach for scoring and ranking candidate genes for their suitability as control genes. Our approach relies on publicly available microarray data and allows the combination of multiple data sets originating from different platforms and/or representing different pathologies. The use of microarray data allows the screening of tens of thousands of genes, producing very comprehensive lists of candidates. We also provide two lists of candidate control genes: one which is breast cancer-specific and one with more general applicability. Two genes from the breast cancer list which had not been previously used as control genes are identified and validated by RT-QPCR. Open source R functions are available at http://www.isrec.isb-sib.ch/~vpopovic/research/
We proposed a new method for identifying candidate control genes for RT-QPCR which was able to rank thousands of genes according to some predefined suitability criteria and we applied it to the case of breast cancer. We also empirically showed that translating the results from microarray to PCR platform was achievable.
基因表达分析已成为一个主要的生物学研究领域,实时定量逆转录PCR(RT-QPCR)是用于选定基因表达谱分析的最准确且应用最广泛的技术之一。为了获得在不同检测中具有可比性的结果,需要一种稳定的标准化策略。一般来说,不同样本间PCR测量值的标准化使用一到几个对照基因(如管家基因),据此构建一个基线参考水平。因此,对照基因的选择至关重要,但目前尚无一种普遍接受的标准技术来筛选大量候选基因并确定最佳基因。
我们提出了一种新方法,用于对候选基因作为对照基因的适用性进行评分和排序。我们的方法依赖于公开可用的微阵列数据,并允许合并来自不同平台和/或代表不同病理的多个数据集。微阵列数据的使用使得能够筛选数万个基因,从而生成非常全面的候选基因列表。我们还提供了两份候选对照基因列表:一份是乳腺癌特异性的,另一份具有更广泛的适用性。通过RT-QPCR鉴定并验证了乳腺癌列表中两个以前未用作对照基因的基因。开源R函数可在http://www.isrec.isb-sib.ch/~vpopovic/research/获取。
我们提出了一种用于鉴定RT-QPCR候选对照基因的新方法,该方法能够根据一些预定义的适用性标准对数千个基因进行排序,并将其应用于乳腺癌的情况。我们还通过实验表明,将微阵列结果转化到PCR平台是可行的。